Congenital thrombotic thrombocytopenic purpura: Lessons for recognition and management of rare syndromes

Pediatric Blood and Cancer

Volumn 50, Issue 5, 2008, Pages 947-948

  George, James N ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE OTITIS MEDIA; CASE REPORT; DIAGNOSTIC APPROACH ROUTE; ENZYME ACTIVITY; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION; LABORATORY DIAGNOSIS; MALE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; SCHOOL CHILD; SHORT SURVEY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 41849099697     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21481     Document Type: Short Survey

References (10)

1. Clark WF, Garg AX, Blake PG, et al. Effect of awareness of a randomized controlled trial on use of experimental therapy. JAMA 2003;290:1351-1355.
2. George JN. Thrombotic thrombocytopenic purpura. New Eng J Med 2006;354:1927-1935.
3. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005;365:1073-1086.
4. Schulman I, Pierce M, Lukens A, et al. Studies on thrombopoiesis. I. A factor in normal plasma required for platelet production: Chronic thrombocytopenia due to its deficiency. Blood 1960; 16:943-957.
5. Upshaw JD, Jr. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. New Eng J Med 1978;298:1350-1352.
6. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. New Eng J Med 1982; 307:1432-1435.
7. Moake JL. Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura. J Thromb Haemost 2004;2:1515-1521.
8. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-494.
9. Furlan M, Lammle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: The role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol 2001;14:437-454.
10. Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: The impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006;108:1267-1279.